Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70746 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Zhenli Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command, Shenyang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Microvessels. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Science Foundation of China, Natural Science Foundation of Liaoning Province, Science and Technology Plan Joint Program of Liaoning Province.
Abstract (Originalsprache)
Liver resection remains the mainstay curative treatment for hepatocellular carcinoma (HCC); however, the recurrence rate is reported to exceed 70% within 5 years after surgery. Microvascular invasion (MVI) has attracted great research interest in the last decade and has been confirmed to be an independent risk factor for postoperative recurrence and survival. Presently, the diagnosis of MVI depends on pathological specimens, which are not helpful in guiding preoperative planning and intraoperative decision‐making. However, preoperative MVI prediction has developed rapidly with the widespread application of predictive models. Besides the well‐defined clinical predictive factors, radiomics and artificial intelligence (AI)‐based models can provide accurate predictions of MVI. In terms of the specific management of MVI, multiple pre‐ and intraoperative therapeutic choices have shown favourable effects in patients at high risk of MVI indicated by predictive models. Several postoperative adjuvant therapies were also demonstrated to be associated with improved surgical outcomes in patients diagnosed with MVI. Considering that the present perspectives concerning MVI‐related management are still controversial, based on the latest research, the present paper provides updated insights into the 1 ) diagnosis and classification of MVI, 2 ) the predictive factors and models of MVI and 3 ) effective therapeutic choices of MVI in pre‐, intra‐ and postoperative processes. The remaining challenges in the management of MVI are highlighted to stimulate further explorations of the precise and individualised management of MVI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command, Shenyang, China.
- Department of General Surgery, The 963rd Hospital of the Joint Service Support Force of the PLA, Jiamusi, China.
- Dalian Medical University, Dalian, China.
- Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China.
Förderung
- Postdoctoral Science Foundation of China
- Natural Science Foundation of Liaoning Province
- Science and Technology Plan Joint Program of Liaoning Province
Zitieren
APA
Li, Z., Xu, L., Zhu, S., Qi, X., Zhang, W., & Tang, Y. (2025). Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70746
Vancouver
Li Z, Xu L, Zhu S, Qi X, Zhang W, Tang Y. Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70746
BibTeX
@article{Li2025,
author = {Li, Zhenli and Xu, Lindi and Zhu, Shuaishuai and Qi, Xingshun and Zhang, Wei and Tang, Yufu},
title = {Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70746}
}
EUVIMED